LP172583-9
SORAfenib
Active
Description
Sorafenib (brand name Nexavar) is in a class of medications called multikinase inhibitors and used to treat advanced renal cell cancer (RCC), hepatocellular cancer (HCC), and thyroid cancer. It is also used to treat recurrent or metastatic angiosarcoma and resistant gastrointestinal stromal tumors (GIST). Adverse effects of sorafenib include loss of appetite, skin rash, weight loss, joint pain, diarrhea, headaches and hypertension. Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- SORAfenib
- Part Display Name
- SORAfenib
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2013-01-30
- Construct for LOINC Short Name
- SORAfenib
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 索拉非尼 Synonyms: 对甲苯磺酸索拉非尼; |
| es-ES | Spanish (Spain) | Sorafenib |
| it-IT | Italian (Italy) | Sorafenib |
| tr-TR | Turkish (Turkey) | Sorafenib |
| ru-RU | Russian (Russian Federation) | Сорафениб |
| nl-NL | Dutch (Netherlands) | sorafenib |
| fr-FR | French (France) | Sorafénib |
| el-GR | Greek (Greece) | Σοραφενίμπη Synonyms: Σοραφενίμπη |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://